-
1
-
-
84930656108
-
NAFLD: A multisystem disease
-
Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol 2015;62(Suppl):S47-S64.
-
(2015)
J Hepatol
, vol.62
, pp. S47-S64
-
-
Byrne, C.D.1
Targher, G.2
-
2
-
-
79957449923
-
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
-
quiz e60
-
Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9:524.e1-530.e1. (quiz e60).
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 524e1-530e1
-
-
Younossi, Z.M.1
Stepanova, M.2
Afendy, M.3
Fang, Y.4
Younossi, Y.5
Mir, H.6
-
3
-
-
84945462807
-
Prevalence of nonalcoholic fatty liver disease and economy
-
Zhu JZ, Dai YN, Wang YM, Zhou QY, Yu CH, Li YM. Prevalence of nonalcoholic fatty liver disease and economy. Dig Dis Sci 2015;60:3194-3202.
-
(2015)
Dig Dis Sci
, vol.60
, pp. 3194-3202
-
-
Zhu, J.Z.1
Dai, Y.N.2
Wang, Y.M.3
Zhou, Q.Y.4
Yu, C.H.5
Li, Y.M.6
-
5
-
-
84911465799
-
Prevalence of non-alcoholic fatty liver disease and its predictors in North of Iran
-
Amirkalali B, Poustchi H, Keyvani H, Khansari MR, Ajdarkosh H, Maadi M, et al. Prevalence of non-alcoholic fatty liver disease and its predictors in North of Iran. Iran J Public Health 2014;43:1275-1283.
-
(2014)
Iran J Public Health
, vol.43
, pp. 1275-1283
-
-
Amirkalali, B.1
Poustchi, H.2
Keyvani, H.3
Khansari, M.R.4
Ajdarkosh, H.5
Maadi, M.6
-
6
-
-
84977100624
-
Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: A systematic review and meta-analysis
-
Wijarnpreecha K, Thongprayoon C, Edmonds PJ, Cheungpasitporn W. Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. QJM 2016;109:461-466.
-
(2016)
QJM
, vol.109
, pp. 461-466
-
-
Wijarnpreecha, K.1
Thongprayoon, C.2
Edmonds, P.J.3
Cheungpasitporn, W.4
-
7
-
-
79955446251
-
Effect of Vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial
-
Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011;305:1659-1668.
-
(2011)
JAMA
, vol.305
, pp. 1659-1668
-
-
Lavine, J.E.1
Schwimmer, J.B.2
Van Natta, M.L.3
Molleston, J.P.4
Murray, K.F.5
Rosenthal, P.6
-
8
-
-
77951874018
-
Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685.
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
McCullough, A.4
Diehl, A.M.5
Bass, N.M.6
-
10
-
-
84895794335
-
Impact of coffee on liver diseases: A systematic review
-
Saab S, Mallam D, Cox GA, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int 2014;34:495-504.
-
(2014)
Liver Int
, vol.34
, pp. 495-504
-
-
Saab, S.1
Mallam, D.2
Cox, G.A.3
Tong, M.J.4
-
11
-
-
0031843679
-
Coffee consumption and decreased serum gammaglutamyltransferase and aminotransferase activities among male alcohol drinkers
-
Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al. Coffee consumption and decreased serum gammaglutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998;27:438-443.
-
(1998)
Int J Epidemiol
, vol.27
, pp. 438-443
-
-
Tanaka, K.1
Tokunaga, S.2
Kono, S.3
Tokudome, S.4
Akamatsu, T.5
Moriyama, T.6
-
12
-
-
84867574518
-
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
-
Anty R, Marjoux S, Iannelli A, Patouraux S, Schneck AS, Bonnafous S, et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 2012;57:1090-1096.
-
(2012)
J Hepatol
, vol.57
, pp. 1090-1096
-
-
Anty, R.1
Marjoux, S.2
Iannelli, A.3
Patouraux, S.4
Schneck, A.S.5
Bonnafous, S.6
-
13
-
-
84905756974
-
Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis
-
Bambha K, Wilson LA, Unalp A, Loomba R, Neuschwander-Tetri BA, Brunt EM, et al. Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int 2014;34:1250-1258.
-
(2014)
Liver Int
, vol.34
, pp. 1250-1258
-
-
Bambha, K.1
Wilson, L.A.2
Unalp, A.3
Loomba, R.4
Neuschwander-Tetri, B.A.5
Brunt, E.M.6
-
14
-
-
80053435971
-
Coffee consumption is associated with a lower incidence of fatty liver in middle-aged men
-
Funatsu K, Yamashita T, Nakamura H. Coffee consumption is associated with a lower incidence of fatty liver in middle-aged men. J Health Sci 2011;57:406-413.
-
(2011)
J Health Sci
, vol.57
, pp. 406-413
-
-
Funatsu, K.1
Yamashita, T.2
Nakamura, H.3
-
15
-
-
84940794698
-
Coffee but not green tea consumption is associated with prevalence and severity of hepatic steatosis: The impact on leptin level
-
Imatoh T, Kamimura S, Miyazaki M. Coffee but not green tea consumption is associated with prevalence and severity of hepatic steatosis: the impact on leptin level. Eur J Clin Nutr 2015;69:1023-1027.
-
(2015)
Eur J Clin Nutr
, vol.69
, pp. 1023-1027
-
-
Imatoh, T.1
Kamimura, S.2
Miyazaki, M.3
-
16
-
-
84856381801
-
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis
-
Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012;55:429-436.
-
(2012)
Hepatology
, vol.55
, pp. 429-436
-
-
Molloy, J.W.1
Calcagno, C.J.2
Williams, C.D.3
Jones, F.J.4
Torres, D.M.5
Harrison, S.A.6
-
17
-
-
84924500492
-
Coffee consumption and nonalcoholic fatty liver onset: A prospective study in the general population
-
Zelber-Sagi S, Salomone F, Webb M, Lotan R, Yeshua H, Halpern Z, et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res 2015;165:428-436.
-
(2015)
Transl Res
, vol.165
, pp. 428-436
-
-
Zelber-Sagi, S.1
Salomone, F.2
Webb, M.3
Lotan, R.4
Yeshua, H.5
Halpern, Z.6
-
18
-
-
77957661914
-
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
-
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-605.
-
(2010)
Eur J Epidemiol
, vol.25
, pp. 603-605
-
-
Stang, A.1
-
19
-
-
84873975790
-
Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review
-
Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public Health 2013;13:154.
-
(2013)
BMC Public Health
, vol.13
, pp. 154
-
-
Herzog, R.1
Alvarez-Pasquin, M.J.2
Diaz, C.3
Del Barrio, J.L.4
Estrada, J.M.5
Gil, A.6
-
22
-
-
43749102686
-
Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway
-
Okano J, Nagahara T, Matsumoto K, Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol 2008;102:543-551.
-
(2008)
Basic Clin Pharmacol Toxicol
, vol.102
, pp. 543-551
-
-
Okano, J.1
Nagahara, T.2
Matsumoto, K.3
Murawaki, Y.4
-
23
-
-
53249092406
-
Pharmacological application of caffeine inhibits TGFbetastimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways
-
Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. Pharmacological application of caffeine inhibits TGFbetastimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008;49:758-767.
-
(2008)
J Hepatol
, vol.49
, pp. 758-767
-
-
Gressner, O.A.1
Lahme, B.2
Rehbein, K.3
Siluschek, M.4
Weiskirchen, R.5
Gressner, A.M.6
-
24
-
-
0035870298
-
The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes
-
McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001;61:3299-3307.
-
(2001)
Cancer Res
, vol.61
, pp. 3299-3307
-
-
McMahon, M.1
Itoh, K.2
Yamamoto, M.3
Chanas, S.A.4
Henderson, C.J.5
McLellan, L.I.6
-
25
-
-
57649194754
-
Coffee, glucose homeostasis, and insulin resistance: Physiological mechanisms and mediators
-
Tunnicliffe JM, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008;33:1290-1300.
-
(2008)
Appl Physiol Nutr Metab
, vol.33
, pp. 1290-1300
-
-
Tunnicliffe, J.M.1
Shearer, J.2
-
26
-
-
77958093867
-
Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach
-
Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP. Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 2010;139:1699-1710.
-
(2010)
Gastroenterology
, vol.139
, pp. 1699-1710
-
-
Kalthoff, S.1
Ehmer, U.2
Freiberg, N.3
Manns, M.P.4
Strassburg, C.P.5
|